- Simplicity, Versatility, Targeted Delivery
- We offer a versatile catheter system for use with both standard and developing therapeutic agents.
- RenovoRx was honored at TiEcon on May 18th, 2013 as one of the only three winning startups in the Life Sciences vertical.
RenovoRx is a medical device company headquartered in Silicon Valley, California.
We are developing solutions for targeted delivery of therapeutic and diagnostic agents
to selected sites in the peripheral vascular system.
RenovoCath™ Catheter System
We do catheters differently. This video shows the RenovoCath special features and the role these features play in delivering therapeutic agents to targeted regions.
In the News
RenovoRx Joins Stanford-Backed StartX Med Program
RenovoRx, a leading developer of innovative solutions for targeted delivery of therapeutics to selected sites in the peripheral vascular system, today announced that the company was selected by the Stanford-affiliated StartX MED program for its Fall 2015 session. StartX is … Continue readingRead More
RenovoRx Receives CE Mark for RenovoCath™
RenovoRx, a leading developer of innovative solutions for targeted delivery of fluids to selected sites in the peripheral vascular system, today announced that the company achieved the CE Mark for commercial sale of the RenovoCath™. The catheter will offer EU … Continue readingRead More
First Patient Enrolled in Study Using the RenovoCath ™
Mountain View, CA (June 3, 2015) – El Camino Hospital in Mountain View, California has enrolled the first patient in a safety study using the RenovoCath™, a new catheter that is being introduced for targeted delivery of fluids to selected … Continue readingRead More
Optimized design for targeted balloon placement
Contact delivery of therapeutic agents